About Rapidx Pathology Labs
Rapidx Pathology Labs was established in 2019 in Viluppuram, India, as a standalone facility in the healthcare diagnostics sector. Core operations involve pathology testing for medical diagnostics, including sample analysis and reporting. Services are delivered to support local healthcare needs, with a focus on routine and specialized tests. The lab functions independently, serving the regional community in southern India.
- Headquarter Viluppuram, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cauro Diagnostics Private Limited
- Date of Incorporation 01 Oct, 2018
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$1.3 M (USD)613.35as on Mar 31, 2021
-
Net Profit
$53.6 K (USD)172.83as on Mar 31, 2021
-
EBITDA
$81.48 K (USD)275.32as on Mar 31, 2021
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Orange health
(Aug 10, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rapidx Pathology Labs
Detailed funding history for Rapidx Pathology Labs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Rapidx Pathology Labs
Rapidx Pathology Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Orange health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
At-home diagnostic tests are booked and collected by phlebotomists.
|
Locked | Locked | Locked |
Investor details for Rapidx Pathology Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rapidx Pathology Labs
Investment portfolio details for Rapidx Pathology Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rapidx Pathology Labs
Detailed financials for Rapidx Pathology Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapidx Pathology Labs Comparisons
Peer comparison for Rapidx Pathology Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rapidx Pathology Labs
Detailed competitors of Rapidx Pathology Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapidx Pathology Labs
Complete news archive for Rapidx Pathology Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rapidx Pathology Labs
Rapidx Pathology Labs was founded in 2019.
Rapidx Pathology Labs is headquartered in Viluppuram, India. It is registered at Viluppuram, Tamil Nadu, India.
Annual revenue of Rapidx Pathology Labs is $1.3M as on Mar 31, 2021.
Rapidx Pathology Labs was established in 2019 in Viluppuram, India, as a standalone facility in the healthcare diagnostics sector. Core operations involve pathology testing for medical diagnostics, including sample analysis and reporting. Services are delivered to support local healthcare needs, with a focus on routine and specialized tests. The lab functions independently, serving the regional community in southern India.
Rapidx Pathology Labs has 1 investor. Key investors include Orange health.